BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25497847)

  • 41. [Intensity modulated radiation therapy for patients with gynecological malignancies after hysterectomy and chemotherapy/radiotherapy].
    Chen ZY; Ma YB; Sheng XG; Zhang XL; Xue L; Song QQ; Liu NF; Miao HQ
    Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):305-8. PubMed ID: 17760262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer.
    Freedman GM; Meropol NJ; Sigurdson ER; Hoffman J; Callahan E; Price R; Cheng J; Cohen S; Lewis N; Watkins-Bruner D; Rogatko A; Konski A
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1389-93. PubMed ID: 17394942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short-course accelerated radiotherapy in palliative treatment of advanced pelvic malignancies: a phase I study.
    Caravatta L; Padula GD; Macchia G; Ferrandina G; Bonomo P; Deodato F; Massaccesi M; Mignogna S; Tambaro R; Rossi M; Flocco M; Scapati A; Scambia G; Pacelli F; Valentini V; Cellini N; Morganti AG
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e627-31. PubMed ID: 22580117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1).
    Ferro M; Chiesa S; Macchia G; Cilla S; Bertini F; Frezza G; Farioli A; Cammelli S; Balducci M; Ianiro A; Angelini AL; Compagnone G; Valentini V; Deodato F; Morganti AG
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):82-90. PubMed ID: 27843034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term results of reirradiation for patients with recurrent rectal carcinoma.
    Mohiuddin M; Marks G; Marks J
    Cancer; 2002 Sep; 95(5):1144-50. PubMed ID: 12209702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase I/II trial of hyperfractionated accelerated chemoradiotherapy for unresectable advanced pancreatic cancer.
    Tsujie M; Nakamori S; Tanaka E; Nagano H; Umeshita K; Dono K; Sakon M; Inoue T; Inoue T; Monden M
    Jpn J Clin Oncol; 2006 Aug; 36(8):504-10. PubMed ID: 16855011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancer.
    Rusthoven KE; Feigenberg SJ; Raben D; Kane M; Song JI; Nicolaou N; Mehra R; Burtness B; Ridge J; Swing R; Lango M; Cohen R; Jimeno A; Chen C
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1020-5. PubMed ID: 20231078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes after reirradiation for recurrent nasopharyngeal carcinoma: North American experience.
    Karam I; Huang SH; McNiven A; Su J; Xu W; Waldron J; Bayley AJ; Kim J; Cho J; Ringash J; Hope A; Chen E; Chan B; Goldstein D; O'Sullivan B; Giuliani ME
    Head Neck; 2016 Apr; 38 Suppl 1():E1102-9. PubMed ID: 26451876
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcome and toxicity for patients treated with intensity modulated radiation therapy for localized prostate cancer.
    Vora SA; Wong WW; Schild SE; Ezzell GA; Andrews PE; Ferrigni RG; Swanson SK
    J Urol; 2013 Aug; 190(2):521-6. PubMed ID: 23415964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
    Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C
    Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II).
    Widder J; Herbst F; Dobrowsky W; Schmid R; Pokrajac B; Jech B; Chiari C; Stift A; Maier A; Karner-Hanusch J; Teleky B; Wrba F; Jakesz R; Poetter R
    Br J Cancer; 2005 Apr; 92(7):1209-14. PubMed ID: 15785745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Palliative pelvic radiotherapy for symptomatic rectal cancer - a prospective multicenter study.
    Cameron MG; Kersten C; Vistad I; van Helvoirt R; Weyde K; Undseth C; Mjaaland I; Skovlund E; Fosså SD; Guren MG
    Acta Oncol; 2016 Dec; 55(12):1400-1407. PubMed ID: 27332723
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperfractionated abdominal reirradiation for gastrointestinal malignancies.
    Hunt A; Das P; Minsky BD; Koay EJ; Krishnan S; Herman JM; Taniguchi C; Koong A; Smith GL; Holliday EB
    Radiat Oncol; 2018 Aug; 13(1):143. PubMed ID: 30086784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Palliative reirradiation for recurrent rectal cancer.
    Lingareddy V; Ahmad NR; Mohiuddin M
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):785-90. PubMed ID: 9240647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Re-irradiation for recurrent rectal cancer - a single-center experience.
    Al-Haidari G; Skovlund E; Undseth C; Rekstad BL; Larsen SG; Åsli LM; Dueland S; Malinen E; Guren MG
    Acta Oncol; 2020 May; 59(5):534-540. PubMed ID: 32056476
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation.
    Jensen G; Tao R; Eng C; Skibber JM; Rodriguez-Bigas M; Chang GJ; You YN; Bednarski BK; Minsky BD; Koay E; Taniguchi C; Krishnan S; Das P
    Adv Radiat Oncol; 2018; 3(4):595-600. PubMed ID: 30370360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial.
    Held T; Lang K; Regnery S; Weusthof K; Hommertgen A; Jäkel C; Tonndorf-Martini E; Krisam J; Plinkert P; Zaoui K; Freudlsperger C; Moratin J; Krauss J; Harrabi SB; Herfarth K; Debus J; Adeberg S
    Radiat Oncol; 2020 Aug; 15(1):190. PubMed ID: 32758267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyperfractionation in the reirradiation of head and neck cancers. Result of a pilot study.
    Benchalal M; Bachaud JM; François P; Alzieu C; Giraud P; David JM; Daly-Schveitzer N
    Radiother Oncol; 1995 Sep; 36(3):203-10. PubMed ID: 8532907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy.
    Dröge LH; Weber HE; Guhlich M; Leu M; Conradi LC; Gaedcke J; Hennies S; Herrmann MK; Rave-Fränk M; Wolff HA
    BMC Cancer; 2015 Oct; 15():750. PubMed ID: 26486986
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reirradiation of locally recurrent rectal cancer: a systematic review.
    Guren MG; Undseth C; Rekstad BL; Brændengen M; Dueland S; Spindler KL; Glynne-Jones R; Tveit KM
    Radiother Oncol; 2014 Nov; 113(2):151-7. PubMed ID: 25613395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.